Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

National Cancer Institute (NCI) · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
small cell carcinoma of the bladder, small cell carcinoma of the urinary tract, squamous cell carcinoma of the bladder, squamous cell carcinoma of the urinary tract, primary adenocarcinoma of the bladder, primary adenocarcinoma of the urinary tract, renal medullary carcinoma, squamous cell carcinoma of the penis, urothelial carcinoma, trophoblastic cell surface antigen 2, programmed death-ligand 1, sn-38
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 851674
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.